534 related articles for article (PubMed ID: 25064728)
1. Influence of pH and method of crystallization on the solid physical form of indomethacin.
Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
[TBL] [Abstract][Full Text] [Related]
2. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
4. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
Censi R; Rascioni R; Di Martino P
Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
[TBL] [Abstract][Full Text] [Related]
5. Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration.
Siddiqui A; Rahman Z; Khan SR; Awotwe-Otoo D; Khan MA
Int J Pharm; 2014 Oct; 473(1-2):545-51. PubMed ID: 25089509
[TBL] [Abstract][Full Text] [Related]
6. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic transformation of indomethacin under high pressures.
Okumura T; Ishida M; Takayama K; Otsuka M
J Pharm Sci; 2006 Mar; 95(3):689-700. PubMed ID: 16432876
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin: new polymorphs of an old drug.
Surwase SA; Boetker JP; Saville D; Boyd BJ; Gordon KC; Peltonen L; Strachan CJ
Mol Pharm; 2013 Dec; 10(12):4472-80. PubMed ID: 24025118
[TBL] [Abstract][Full Text] [Related]
9. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.
Bookwala M; Thipsay P; Ross S; Zhang F; Bandari S; Repka MA
Eur J Pharm Biopharm; 2018 Oct; 131():109-119. PubMed ID: 30086393
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
13. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
14. Effect of counterion on the phase behaviour during lyophilization of indomethacin salt forms.
Kumar L; Baheti A; Mokashi A; Bansal AK
Eur J Pharm Sci; 2011 Sep; 44(1-2):136-41. PubMed ID: 21767640
[TBL] [Abstract][Full Text] [Related]
15. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the acid-base reaction between solid indomethacin and sodium bicarbonate using infrared spectroscopy, X-ray powder diffraction, and solid-state nuclear magnetic resonance spectroscopy.
Chen X; Griesser UJ; Te RL; Pfeiffer RR; Morris KR; Stowell JG; Byrn SR
J Pharm Biomed Anal; 2005 Jul; 38(4):670-7. PubMed ID: 15967295
[TBL] [Abstract][Full Text] [Related]
17. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
[TBL] [Abstract][Full Text] [Related]
19. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
[TBL] [Abstract][Full Text] [Related]
20. Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
Araya-Sibaja AM; Soldi V; Campos CE; Cardoso SG; Cuffini SL
Drug Dev Ind Pharm; 2015 May; 41(5):851-8. PubMed ID: 24758712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
